PBH101 GROUP ASSIGNMENT
Submitted To:
Barnali Chakraborty
(MSc, MPH, PhD)
Assistant Professor
Dept. of Public Health,
School of Health & Life Sciences
North South University
Submitted by:
NAME
NSU ID
Imtiaz Khan
2411885630
Nazifa Tasnim
2411924630
Shanjana Tasneem
2411646615
Tasfia Jahan Niha
2411949630
Mysha Mahjabin
2412031615
S. M. Maheer Labib
2411996030
Report on Depression: Symptoms, Causes, and Solutions
Introduction
Depression is a pervasive and debilitating mental health disorder that affects
millions of people worldwide. According to the World Health Organization (WHO,
2023), over 280 million individuals suffer from depression, making it one of the
leading causes of disability globally. This report provides an in-depth analysis of
depression, covering its symptoms, causes, risk factors, global impact, and
potential solutions. The goal is to enhance understanding, reduce stigma, and
highlight effective strategies for prevention and treatment.
Depression is not merely a temporary feeling of sadness but a serious medical
condition that impacts emotional, physical, and cognitive functioning. Despite its
prevalence, many individuals do not seek help due to stigma, lack of awareness,
or limited access to mental health services. By examining the multifaceted nature
of depression, this report aims to contribute to a broader conversation on mental
health and advocate for better support systems.
Symptoms of Depression
Depression manifests through a range of symptoms that can be categorized into
emotional, physical, and cognitive domains. Recognizing these signs is crucial for
early intervention and effective treatment.
1. Emotional Symptoms

Persistent sadness, hopelessness, or emptiness

Loss of interest or pleasure in previously enjoyed activities

Irritability, frustration, or restlessness

Feelings of guilt or worthlessness
2. Physical Symptoms

Chronic fatigue and low energy levels

Sleep disturbances (insomnia or excessive sleeping)

Changes in appetite (overeating or loss of appetite) leading to weight
fluctuations

Unexplained aches, pains, or digestive issues
3. Cognitive Symptoms

Difficulty concentrating, making decisions, or remembering details

Negative thought patterns, self-criticism, and pessimism

Recurrent thoughts of death or suicide
These symptoms often persist for weeks or months and significantly impair daily
functioning. A hypothetical case study of a young adult experiencing depression
after a major life event (e.g., job loss or a breakup) illustrates how these
symptoms can disrupt personal and professional life.
Causes and Risk Factors of Depression
Depression arises from a complex interplay of genetic, biological, environmental,
and psychological factors. Understanding these causes helps in developing
targeted interventions.
1. Genetic Factors

Family history plays a significant role, with twin studies indicating a 40-50%
heritability rate.

Certain genetic mutations may increase susceptibility to mood disorders.
2. Biological Factors

Imbalances in neurotransmitters (serotonin, dopamine, norepinephrine)
affect mood regulation.

Brain imaging studies show structural and functional differences in
depressed individuals.

Hormonal changes (e.g., postpartum depression, menopause) can trigger
depressive episodes.
3. Environmental Factors

Traumatic experiences (abuse, loss of a loved one, financial stress)

Chronic illness or pain

Social isolation or lack of support systems
4. Psychological Factors

Negative thought patterns and cognitive distortions

Low self-esteem and perfectionism

History of anxiety or other mental health disorders
A fictional example of an individual with a family history of depression who
undergoes a stressful life event demonstrates how these factors interact to trigger
a depressive episode.
Global Burden of Depression
Depression has far-reaching consequences on individuals, communities, and
economies. Key trends include:
1. Rising Prevalence

The COVID-19 pandemic increased depression rates by 25% (The Lancet,
2021).

Adolescents and young adults are particularly vulnerable, with suicide being
a leading cause of death among those aged 10-24 (CDC, 2022).
2. Economic Impact

Depression costs the global economy approximately $1 trillion annually in
lost productivity (WHO, 2019).

Workplace absenteeism and reduced efficiency contribute to economic
strain.
3. Regional Disparities

Low- and middle-income countries face higher depression rates due to
limited mental health resources.

Rural areas often lack access to mental health professionals compared to
urban centers.
4. Vulnerable Populations

Women: Experience depression at twice the rate of men (NIMH).

Elderly: Frequently underdiagnosed, leading to higher suicide rates (18 per
100,000).

LGBTQ+ Individuals: Face elevated risks due to discrimination and social
stigma.

Low-Income Groups: Financial stress and lack of healthcare access increase
susceptibility.
These disparities highlight the need for targeted mental health policies and
equitable resource distribution.
Treatment and Management Strategies
Depression is treatable through a combination of medical, psychological, and
lifestyle interventions.
1. Psychotherapy

Cognitive Behavioral Therapy (CBT): Helps reframe negative thought
patterns (50-75% success rate).

Interpersonal Therapy (IPT): Focuses on improving relationships and social
support.

Psychodynamic Therapy: Explores unconscious influences from past
experiences.
2. Medication

SSRIs (e.g., Prozac, Zoloft): Increase serotonin levels.

SNRIs (e.g., Cymbalta, Effexor): Boost serotonin and norepinephrine.

Tricyclic Antidepressants (TCAs): Older medications with more side effects.
3. Lifestyle Modifications

Exercise: Releases endorphins and reduces stress.

Balanced Diet: Omega-3 fatty acids and whole grains support brain health.

Sleep Hygiene: 7-9 hours of quality sleep improves mood regulation.
4. Public Health Initiatives

Mental health awareness campaigns

School-based screening programs

Crisis hotlines (e.g., National Suicide Prevention Lifeline)
A case study of a community-based therapy program showed a 30% reduction in
depressive symptoms among participants, demonstrating the effectiveness of
combined approaches.
Future Directions in Depression Treatment
Innovations in mental healthcare offer promising avenues for improving
depression management:
1. Early Intervention

Routine mental health screenings in schools and primary care settings.
2. Telehealth Expansion

Online therapy and remote consultations increase accessibility, especially in
rural areas.
3. Precision Medicine

Genetic testing to tailor treatments based on individual biological profiles.
4. Policy Reforms

Increased funding for mental health services.

Insurance coverage for therapy and medications.
These advancements could revolutionize depression treatment, making it more
personalized and accessible.
Conclusion and Call to Action
Depression is a complex but treatable condition that requires a multifaceted
approach. Key takeaways include:

Early recognition of symptoms leads to better outcomes.

Combined treatments (therapy, medication, lifestyle changes) are most
effective.

Global disparities in mental healthcare must be addressed through policy
changes.
Recommendations:
1. Increase mental health education to reduce stigma.
2. Expand access to affordable care, particularly in underserved regions.
3. Support research into new treatment methods.
By fostering empathy, advocating for policy changes, and promoting mental
wellness, society can create a more inclusive future where individuals receive the
care they deserve.
Citations:
1. Yasamy, M. T., & Saxena, S. (2012). Depression: A global public health concern.
World Health Organization. https://www.researchgate.net/profile/Mohammad-TaghiYasamy/publication/285075782_Depression_A_global_public_health_concern/links/5a3
6303345851532e82fb8f2/Depression-A-global-public-health-concern.pdf
2. Chisholm, D., Sweeny, K., Sheehan, P., Rasmussen, B., Smit, F., Cuijpers, P., &
Saxena, S. (2016). Scaling-up treatment of depression and anxiety: A global return on
investment analysis. The Lancet Psychiatry, 3(5), 415–424.
https://www.researchgate.net/publication/299341186_Scalingup_treatment_of_depression_and_anxiety_A_global_return_on_investment_analysis/fullt
ext/5738c3a308aea45ee83eb578/Scaling-up-treatment-of-depression-and-anxiety-Aglobal-return-on-investment-analysis.pdf
3. Kong, X., & Wang, Y. (2024). Global, regional, and national burdens of depression in
adolescents and young adults aged 10–24 years from 1990 to 2019: Findings from the
2019 Global Burden of Disease Study. The Lancet Child & Adolescent Health.
https://www.researchgate.net/publication/380098139_Global_regional_and_national_bur
dens_of_depression_in_adolescents_and_young_adults_aged_1024_years_from_1990_to_2019_findings_from_the_2019_Global_Burden_of_Disease_st
udy